Korean J Intern Med.
2020 Nov;35(6):1336-1337. 10.3904/kjim.2020.535.
Do all patients with breast cancer benefit from neoadjuvant chemotherapy?
- Affiliations
-
- 1Division of HematologyOncology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea
- KMID: 2508129
- DOI: http://doi.org/10.3904/kjim.2020.535
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
- Life-Threatening Hematoma in an Elderly Breast Cancer Patient Undergoing Chemotherapy
- Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancerâ€
- The Influence of Anxiety, Uncertainty, and Cancer Coping on the Quality of Life in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
- Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer
